万人牛牛 Partners with SAFE Project to Combat Overdoses on Project Sites with Naloxone and Response Training

On-site First Aid
(
May 07, 2024
)

Safety is one of our core company values and that is why we鈥檝e partnered with to take on the .  This commitment signifies our efforts to respond to the opioid epidemic which has adversely impacted and continues to impact many in our line of work. According to a CDC study, the construction industry has experienced the highest death rate of drug overdoses.

鈥淎t 万人牛牛 we are committed to making sure that all of our employees and subcontractor partners make it home to their families safely at the end of the day,鈥 said Brian Murray, our Chief Executive Officer. 鈥淥ur team is taking initiative to ensure we are prepared, educated and willing to intervene to save someone鈥檚 life.鈥

We plan to make naloxone available on more than 100 project sites and in all our offices by the end of summer. In addition, overdose response training will be made available annually to employees through online courses and in-person demonstrations. These programs are being coordinated in partnership with , a national nonprofit that has provided naloxone training to 10,000 people nationwide.

鈥淭he opioid epidemic has severely impacted the construction industry in recent years, and we realize it鈥檚 more important now than ever for our teams to have access to life-saving opioid reversal medication,鈥 said John Gaddini, our Corporate Safety Director. 鈥淥ur hope is that employees will never have to administer naloxone but with the training they will receive, they will be ready to act in the event of a life-threatening scenario.鈥

Overdose deaths in the construction industry increased nine times from 2011 to 2018, according to the CDC. Research from the CDC shows that one out of three construction workers have suffered soft-tissue injuries such as carpal tunnel syndrome, tendinitis and rotator cuff injuries, and prescription opioid use is three times higher among construction workers with these ailments.

Naloxone is a life-saving opioid reversal medication. Last year, the Food and Drug Administration approved naloxone for non-prescription, over-the-counter use for the first time.